关注
Fredrik Hieronymus
Fredrik Hieronymus
在 neuro.gu.se 的电子邮件经过验证
标题
引用次数
引用次数
年份
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
F Hieronymus, JF Emilsson, S Nilsson, E Eriksson
Molecular psychiatry 21 (4), 523-530, 2016
2162016
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors
F Hieronymus, S Nilsson, E Eriksson
Translational psychiatry 6 (6), e834-e834, 2016
1042016
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis
F Hieronymus, A Lisinski, S Nilsson, E Eriksson
The Lancet Psychiatry 6 (9), 745-752, 2019
652019
The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: a systematic review and meta-analysis
TD Nguyen, F Hieronymus, R Lorentzen, A McGirr, SD Østergaard
Journal of Affective Disorders 279, 250-255, 2021
622021
Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression
F Hieronymus, A Lisinski, S Nilsson, E Eriksson
Molecular Psychiatry 23 (8), 1731-1736, 2018
542018
Optimizing psychiatric care during the COVID‐19 pandemic
MM Madsen, D Dines, F Hieronymus
Acta Psychiatrica Scandinavica 142 (1), 70, 2020
392020
The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis
R Lorentzen, TD Nguyen, A McGirr, F Hieronymus, SD Østergaard
Schizophrenia 8 (1), 35, 2022
342022
Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study
A Lisinski, F Hieronymus, J Näslund, S Nilsson, E Eriksson
Neuropsychopharmacology 45 (3), 553-560, 2020
302020
Effects of selective serotonin reuptake inhibitors on rating-scale-assessed suicidality in adults with depression
J Näslund, F Hieronymus, A Lisinski, S Nilsson, E Eriksson
The British Journal of Psychiatry 212 (3), 148-154, 2018
282018
One (effect) size does not fit at all: interpreting clinical significance and effect sizes in depression treatment trials
F Hieronymus, S Jauhar, SD Østergaard, AH Young
Journal of Psychopharmacology 34 (10), 1074-1078, 2020
262020
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression
J Näslund, F Hieronymus, JF Emilsson, A Lisinski, S Nilsson, E Eriksson
Acta Psychiatrica Scandinavica 136 (4), 343-351, 2017
262017
Pre‐diagnostic and post‐diagnostic psychopharmacological treatment of 16 288 patients with bipolar disorder
O Köhler‐Forsberg, C Gasse, F Hieronymus, L Petersen, RH Christensen, ...
Bipolar disorders 23 (4), 357-367, 2021
222021
Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis
F Hieronymus, A Lisinski, E Eriksson, SD Østergaard
Translational psychiatry 11 (1), 249, 2021
222021
On the application of machine learning techniques to regression problems in sea level studies
M Hieronymus, J Hieronymus, F Hieronymus
Journal of Atmospheric and Oceanic Technology 36 (9), 1889-1902, 2019
192019
Low SSRI dosing in clinical practice—a register‐based longitudinal study
A Lisinski, F Hieronymus, E Eriksson, SM Wallerstedt
Acta Psychiatrica Scandinavica 143 (5), 434-443, 2021
112021
The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective
L Boschloo, F Hieronymus, A Lisinski, P Cuijpers, E Eriksson
Translational Psychiatry 13 (1), 19, 2023
102023
Multiple possible inaccuracies cast doubt on a recent report suggesting selective serotonin reuptake inhibitors to be toxic and ineffective
F Hieronymus, A Lisinski, J Näslund, E Eriksson
Acta neuropsychiatrica 30 (5), 244-250, 2018
102018
Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom‐specific approach
L Boschloo, F Hieronymus, P Cuijpers, ICECA Work Group, A Lisinski, ...
World Psychiatry 21 (1), 152-153, 2022
82022
Individual variability in treatment response to antidepressants in major depression: comparing trial‐level and patient‐level analyses.
F Hieronymus, M Hieronymus, S Nilsson, E Eriksson, SD Østergaard
Acta Psychiatrica Scandinavica 142 (6), 2020
82020
Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis
F Hieronymus, P Kølbæk, CU Correll, SD Østergaard
npj Schizophrenia 7 (1), 41, 2021
72021
系统目前无法执行此操作,请稍后再试。
文章 1–20